After seasons of declining numbers and five years without any female cross country runners, Southwestern Community College announced they are beginning to phase out the college’s running programs. In ...

Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...

Running Start program faces possible cuts Washington lawmakers are considering cutting summer classes from the Running Start program, which lets high school students earn college credits tuition-free.

Luke Lindberg, USDA's undersecretary for trade and foreign agricultural affairs. (USDA photo) Luke Lindberg, USDA’s undersecretary for trade and foreign agricultural affairs, is the leading contender ...

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

In uncertain times, focus on your strengths and use AI to deepen customer trust, not chase distractions. Data-driven decisions and transparent communication help businesses stay resilient when ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

Texas’ medical marijuana program is expanding, with new laws now in effect that increase access for patients across the state, including in North Texas. While much of the debate in 2025 centered on ...

Much is being said about the wonders of artificial intelligence (AI) and how it is the new frontier. And while it provides amazing possibilities in fields like medicine, academics are debating its ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.